Literature DB >> 26387401

Twin Reversed Arterial Perfusion (TRAP) Sequence: A Case Report and Review of Treatment.

Tongta Nanthakomon, Athita Chanthasenanont, Charintip Somprasit, Sakol Manusook, Densak Pongrojpaw, Komsun Suwannarurk.   

Abstract

A cardiac twin or twin reversed arterial perfusion (TRAP) sequence is a rare unique complication of monozygotic multiple pregnancy. In this disorder, there is a normally formed donor (the pump twin) who has features of congestive heart failure (CHF) as well as a recipient (the acardiac twin) who lacks a well-defined a heart structure. Also evident are other structures, namely the TRAP sequencefrom pump to acardiacfetus via single artery-to-artery and vein-to-vein anastomoses directly between the two cords or indirectly on the chorionic plate. Overall, the perinatal mortality rate for the pump twin is 35-55%. Prenatal diagnosis and prognosis factors can be examined through ultrasound. The optimal management of a cardiac twin pregnancies is controversial. The expected treatment of acardiac anomaly presently relies on maximizing the chance ofterm delivery and preventing CHF in the healthy pump twin or interrupting vascularization between the two twins. This article reported the experience of acardiac twin management in Thammasat University Hospital and reviewed the current knowledge ofthe condition, prenatal diagnosis, prognosis factor and management options focusing on conservative management compared to invasive treatment.

Entities:  

Mesh:

Year:  2015        PMID: 26387401

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Single Fetal Demise at 10 - 14 Weeks of Monochorionic and Dichorionic Twin Pregnancy.

Authors:  Shunji Suzuki
Journal:  J Clin Med Res       Date:  2016-02-27

2.  A new method for selective reduction in TRAP sequence with a contraindication to fetoscopic surgery: A case report.

Authors:  Qi Li; Xin-Hua Wu; Wei-She Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.